IRADIMED CORPORATION (IRMD)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:24AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 537.85M |
| Enterprise value | 494.66M |
| Trailing P/E | 30.34 |
| Forward P/E | 27.55 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.99 |
| Price/book (mrq) | 7.07 |
| Enterprise value/revenue | 7.31 |
| Enterprise value/EBITDA | 22.92 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.87 |
| 52-week change 3 | -10.50% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 51.04 |
| 52-week low 3 | 36.12 |
| 50-day moving average 3 | 42.43 |
| 200-day moving average 3 | 43.44 |
Share statistics
| Avg vol (3-month) 3 | 47.69k |
| Avg vol (10-day) 3 | 35.74k |
| Shares outstanding 5 | 12.66M |
| Implied shares outstanding 6 | 12.66M |
| Float 8 | 7.16M |
| % held by insiders 1 | 37.04% |
| % held by institutions 1 | 54.40% |
| Shares short (15 May 2024) 4 | 97.61k |
| Short ratio (15 May 2024) 4 | 2 |
| Short % of float (15 May 2024) 4 | 1.22% |
| Short % of shares outstanding (15 May 2024) 4 | 0.77% |
| Shares short (prior month 15 Apr 2024) 4 | 104.88k |
Dividends & splits
| Forward annual dividend rate 4 | 0.6 |
| Forward annual dividend yield 4 | 1.41% |
| Trailing annual dividend rate 3 | 0.15 |
| Trailing annual dividend yield 3 | 0.35% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 10.71% |
| Dividend date 3 | 30 May 2024 |
| Ex-dividend date 4 | 17 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 26.48% |
| Operating margin (ttm) | 26.98% |
Management effectiveness
| Return on assets (ttm) | 15.87% |
| Return on equity (ttm) | 25.52% |
Income statement
| Revenue (ttm) | 67.69M |
| Revenue per share (ttm) | 5.36 |
| Quarterly revenue growth (yoy) | 13.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 21.59M |
| Net income avi to common (ttm) | 17.92M |
| Diluted EPS (ttm) | 1.40 |
| Quarterly earnings growth (yoy) | 21.40% |
Balance sheet
| Total cash (mrq) | 45.13M |
| Total cash per share (mrq) | 3.56 |
| Total debt (mrq) | 1.94M |
| Total debt/equity (mrq) | 2.55% |
| Current ratio (mrq) | 9.44 |
| Book value per share (mrq) | 6.01 |
Cash flow statement
| Operating cash flow (ttm) | 12.7M |
| Levered free cash flow (ttm) | 6.76M |
© 2024 Yahoo. All rights reserved.